No Detail Found!

Pain and inflammation profile of a degenerated intervertebral disc

Author(s)
Sobia Ekram Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi,Karachi-75270,Pakistan
Shafiqa Naeem Rajput Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi,Karachi-75270,Pakistan
Shumaila Khalid Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi,Karachi-75270,Pakistan
Faiza Ramzan Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi,Karachi-75270,Pakistan
Asmat Salim Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi,Karachi-75270,Pakistan
Irfan Khan Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi,Karachi-75270,Pakistan
Abstract
Degenerative disc disease (DDD) is characterized by progressive intervertebral disc (IVD) inflammation that ultimately causes lower back pain (LBP). In the present investigation, the rat needle punctured IVD degeneration (IVDD) model was established under a fluoroscopically guided system, followed by human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) transplantation. Quantitative real-time polymerase chain reaction (qPCR) was performed to quantify the pain and inflammatory molecular markers, including C-JUN, C-FOS, serine /threonine protein kinase (AKT), osteoprotegerin (OPG), receptor activator of nuclear factor ? B (RANK), toll-like receptor 4 (TLR4) and interleukin 1 beta (IL1-ß). Radiographic imaging and histological analyses showed significant IVDD after two weeks of injury, and the hUC-MSC group exhibited the restored nucleus pulposus (NP) region and the significant presence of proteoglycans in contrast to the degenerated group. When compared to healthy IVDs, the molecular expression of pain and inflammatory genes was significantly increased on days 2 and 5, resulting in an immunomodulatory response and a marked IVDD. Conversely, the hUC-MSC group at 2 and 5 days showed significantly downregulated expression of C-JUN (***p = 0.001 and **p = 0.01 respectively), C-FOS (**p = 0.01), OPG (***p = 0.001 on day 2), RANK (**p = 0.01), TLR4 (***p = 0.001 on day 5) and IL1-ß (**p = 0.01 on day 2), compared to the IVDD group. MSCs transplanted group also showed significant upregulation on days 2 and 5 in the anti-inflammatory marker AKT (***p = 0.001 and **p = 0.01, respectively) expression. Moreover, the hUC-MSCs-treated group indicated significant NP hydration. The preclinical transplantation of hUC-MSCs can potentially reduce the pain and inflammation caused by disc degeneration. Therefore, the therapy can ideally deal with all the manifestations that occur due to such debilitating DDD.
Publication Details
Page(s) 101-119
Published Journal: Molecular Medicine Communications, Volume: 2, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Pain, Regeneration, inflammation, Degenerative disc disease, intervertebral disc
0

Citations

0

Downloads

29

Views